fludarabine has been researched along with Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Agil, A; Al-Ahmari, A; Al-Seraihi, A; Ayas, M; Ayas, MF; Ghemlas, I | 1 |
| Hogan, JJ; Weiss, BM | 1 |
| Angelucci, E; Baronciani, D; Depau, C; Di Bartolomeo, P; Iori, AP; Mico, C; Pettinau, M; Pilo, F; Rambaldi, A; Santarone, S | 1 |
| Kersting, S; Verdonck, LF | 1 |
| Herrera, GA; Isaac, J | 1 |
| Imamura, T; Kadota, J; Kikuchi, H; Kohno, K; Ogata, M; Ohtsuka, E; Tomo, T | 1 |
| Leach, M; Parsons, RM; Reilly, JT; Winfield, DA | 1 |
1 review(s) available for fludarabine and Kidney Diseases
| Article | Year |
|---|---|
Bridging the Divide: An Onco-Nephrologic Approach to the Monoclonal Gammopathies of Renal Significance.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Immunoglobulins; Immunosuppressive Agents; Kidney Diseases; Lenalidomide; Melphalan; Oligopeptides; Paraproteinemias; Pentostatin; Rituximab; Thalidomide; Vidarabine | 2016 |
1 trial(s) available for fludarabine and Kidney Diseases
| Article | Year |
|---|---|
Treosulfan/fludarabine as an allogeneic hematopoietic stem cell transplant conditioning regimen for high-risk patients.
Topics: Adolescent; Adult; Aged; Busulfan; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Comorbidity; Digestive System Diseases; Feasibility Studies; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Middle Aged; Myeloablative Agonists; Prospective Studies; Reoperation; Risk; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2008 |
5 other study(ies) available for fludarabine and Kidney Diseases
| Article | Year |
|---|---|
Successful hematopoietic cell transplantation in Fanconi anemia patients with renal impairment using ultra-reduced doses of cyclophosphamide and fludarabine.
Topics: Cyclophosphamide; Fanconi Anemia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kidney Diseases; Male; Transplantation Conditioning; Vidarabine | 2018 |
Successful outcome after nonmyeloablative allogeneic hematopoietic stem cell transplantation in patients with renal dysfunction.
Topics: Adult; Aged; Antineoplastic Agents; Cyclosporine; Disease-Free Survival; Female; Glomerular Filtration Rate; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Mycophenolic Acid; Survival Rate; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation | 2008 |
Cast nephropathy in a case of Waldenström's macroglobulinemia.
Topics: Aged; Biopsy; Female; Humans; Immunoglobulin A; Immunohistochemistry; Immunosuppressive Agents; Kidney Diseases; Kidney Glomerulus; Renal Dialysis; Vidarabine; Waldenstrom Macroglobulinemia | 2002 |
Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
Topics: Adult; Amyloidosis; Diarrhea; Drug Therapy, Combination; Heart Diseases; Humans; Hypotension; Japan; Kidney Diseases; Male; Melphalan; Myeloablative Agonists; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation Conditioning; Transplantation, Homologous; Vidarabine | 2006 |
Efficacy of urate oxidase (uricozyme) in tumour lysis induced urate nephropathy.
Topics: Aged; Allantoin; Antimetabolites, Antineoplastic; Diuresis; Drug Evaluation; Female; Humans; Kidney Calculi; Kidney Diseases; Kidney Tubules; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Oliguria; Treatment Outcome; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid; Vidarabine | 1998 |